Beckman Coulter Life Sciences Features Automated Solutions and Systems for NGS, Screening, Cell Analysis at SLAS 2014
Two automated solutions workshops highlight Beckman Coulter’s events at SLAS. The first presentation, Unlocking FFPE tissues: A new approach to the automation of library preparation of archival samples for RNA-Seq, takes place in Room 28B on Tues., Jan. 20 from 12:30-1:45 p.m. and will be presented by Michaela Bowden PhD, CMOP Associate Director, Dana Farber Cancer Institute; Mary Blair, Senior Applications Scientist, Beckman Coulter Life Sciences; and Cristine Kinross, Senior Product Manager at Epicentre, an Illumina company.
The second seminar, A high-throughput and reproducible workflow for targeted mass spectrometry applied to large scale analysis of clinical samples, will be presented in room 24C by Jennifer E. Van Eyk, Director, Johns Hopkins NHLBI Proteomics Center, Johns Hopkins School of Medicine, on Mon., Jan. 21 from 12:30-1:15 p.m.
Booth 605 will feature four sections: Screening, Genomics, Analytical Technologies and Cell Line Development. Within the booth, attendees on Monday and Tuesday have the opportunity to attend educational presentations on NGS library preparation, partnering for successful integration, leveraging the value of automated high content screening and related topics. Beckman Coulter Life Sciences’ platforms will be integrated with company instruments and those of other vendors in workstations for sequencing sample prep, cell analysis, mass spec, pharmaceutical analysis and other methods and processes.
Next generation sequencing will be a focal point of the meeting, with the benefits of low, medium and high throughput solutions addressed in the FFPE seminar and in-booth presentations, including featured products, systems and methods that address each step in the NGS workflow.
“SLAS is an important meeting, and a great place to demonstrate our deep involvement and long association with research automation,” said Patrick O’Donnell, Director Life Science Marketing Americas, Beckman Coulter Life Sciences. “We look forward to seeing our customers as well as our partners, and will likely learn as much from them as they learn from us.”
Capping the company’s activities will be a half-dozen poster sessions, covering everything from escalating cancer research to reducing costs by automating liquid handling, and from automated IgG sample prep for pharmaceutical analysis to a high-throughput workflow for targeted mass spec applied to clinical samples.